跳至主要内容
临床试验/EUCTR2019-002923-13-IT
EUCTR2019-002923-13-IT进行中(未招募)1 期

Indication for the exougenous surfactant administration to treat neonatal respiratory distress syndrome in the preterm infant: a single-center randomized phase 4 trial based on the comparison of two levels of respiratory severity. - respiratory severity and exogenous surfactant

AZIENDA OSPEDALIERO-UNIVERSITARIA OSPEDALI RIUNITI DI ANCONA0 个研究点目标入组 200 人开始时间: 2020年10月22日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - gestational age between 24 and 32 weeks postmenstrual age;
  • - diagnosis of neonatal respiratory distress (RDS);
  • - need of invasive/non-invasive ventilatory support;
  • - written informed consent.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - congenital malformations;
  • - genetic disorders;
  • - perinatal asphyxia;
  • - presence or concomitance of other diseases compatible with RDS.

研究者

相似试验